RELEASE: Esaote Unveils the World Premiere of Its New MyLab™X90 Ultrasound Device

(Information sent by the signatory company).

RELEASE: Esaote Unveils the World Premiere of Its New MyLab™X90 Ultrasound Device

(Information sent by the signatory company)

An innovative premium system that combines exceptional performance with artificial intelligence to optimize workflows and support advanced, interconnected healthcare systems

MANAMA, Bahrain, Jan. 26, 2023 /PRNewswire/ -- Esaote, a leading Italian company in the biomedical sector (in ultrasound, dedicated MRI and medical informatics), today presents the world premiere of MyLab™X90, its new premium ultrasound.

"Precision and accuracy throughout the imaging chain, speed of data processing and AI-based native application management are at the heart of MyLab™X90," said Guillaume Gauthier, Global Marketing Director of ultrasound products. "In addition to providing high-quality imaging and advanced clinical solutions, our goal was to revolutionize daily workflows by increasing the speed and accuracy of analysis, as well as improving the operator experience and clinical outcome for patients."

MyLab™X90 offers premium components, where the starting points are the renewal of the XCrystal family of sonars and Barco's exclusive dual-layer eLed monitor. These ensure an excellent display of images on the screen with a very high contrast resolution, far superior to other product lines.

MyLab™X90 also offers advanced ergonomics in operator-centric clinical solutions, which extend data analysis capabilities and ensure a unique customer experience based on diagnostic confidence, as well as automation to improve usability and availability of technologies. advanced in daily clinical practice.

"We are very pleased with this result, which is the result of substantial investment and intensive R&D work. The new MyLab™X90, with its all-Italian design, represents a new evolution in the range of technologies we offer to help with caring for people and well-being", said Franco Fontana, CEO of Esaote. "It represents the result of a strategic investment and of our international and multidisciplinary team, which can meet the challenges of innovation and anticipate the requirements of the most advanced and interconnected healthcare systems. We believe that these aspects, combined with the latest technologies, can make a significant contribution to improving the level of patient care and we are delighted to play an active role."

For its world premiere, Esaote selected Manama, an international context and a vibrant multicultural hub. The event, which will be attended by the Bahraini authorities and international clinical experts, will be streamed live on the EsaoteLinkedIn page ( and will be available afterwards on demand at

The new MyLab™X90 will be on display at Arab Health 2023 (Dubai, January 30-February 2) and at the European Congress of Radiology (ECR) 2023, Vienna from March 1-5.

510(k) pending at FDA, not available for sale in the US.


The Esaote Group, which celebrated 40 years of activity last year, is a leader in the biomedical equipment sector, particularly in the areas of ultrasound, magnetic resonance imaging and software for managing the diagnostic process. At the end of 2021, the Group had 1,280 employees, more than half of whom were in Italy. With headquarters in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in 100 countries around the world.

Photo - -

View original content: